Atria Wealth Solutions Inc. Grows Stock Holdings in The Clorox Company (NYSE:CLX)

Atria Wealth Solutions Inc. lifted its position in shares of The Clorox Company (NYSE:CLX - Free Report) by 24.6% during the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 33,456 shares of the company's stock after purchasing an additional 6,604 shares during the quarter. Atria Wealth Solutions Inc.'s holdings in Clorox were worth $5,434,000 as of its most recent filing with the Securities & Exchange Commission.

Several other hedge funds also recently made changes to their positions in CLX. State Street Corp boosted its stake in shares of Clorox by 3.1% in the third quarter. State Street Corp now owns 8,182,109 shares of the company's stock worth $1,332,947,000 after acquiring an additional 245,525 shares during the period. Mizuho Securities USA LLC raised its holdings in shares of Clorox by 46,877.8% in the third quarter. Mizuho Securities USA LLC now owns 4,500,000 shares of the company's stock worth $733,095,000 after buying an additional 4,490,421 shares during the period. Geode Capital Management LLC raised its holdings in shares of Clorox by 1.1% in the third quarter. Geode Capital Management LLC now owns 3,028,333 shares of the company's stock worth $491,713,000 after buying an additional 33,970 shares during the period. Stifel Financial Corp raised its holdings in shares of Clorox by 1.7% in the third quarter. Stifel Financial Corp now owns 2,334,826 shares of the company's stock worth $380,370,000 after buying an additional 37,967 shares during the period. Finally, Van ECK Associates Corp raised its holdings in shares of Clorox by 2.2% in the third quarter. Van ECK Associates Corp now owns 1,492,717 shares of the company's stock worth $237,372,000 after buying an additional 31,510 shares during the period. 78.53% of the stock is currently owned by institutional investors.

Clorox Stock Performance

Shares of CLX traded up $4.08 during midday trading on Friday, reaching $157.15. 1,116,697 shares of the stock were exchanged, compared to its average volume of 1,314,486. The business's 50-day moving average price is $157.87 and its 200 day moving average price is $159.63. The company has a debt-to-equity ratio of 20.52, a current ratio of 0.94 and a quick ratio of 0.60. The Clorox Company has a twelve month low of $127.60 and a twelve month high of $171.37. The company has a market capitalization of $19.36 billion, a price-to-earnings ratio of 42.94, a PEG ratio of 2.58 and a beta of 0.42.

Clorox (NYSE:CLX - Get Free Report) last posted its earnings results on Monday, February 3rd. The company reported $1.55 EPS for the quarter, topping analysts' consensus estimates of $1.39 by $0.16. Clorox had a return on equity of 316.87% and a net margin of 6.38%. During the same quarter in the previous year, the company earned $2.16 EPS. On average, sell-side analysts expect that The Clorox Company will post 7.15 EPS for the current fiscal year.

Analysts Set New Price Targets

Several equities research analysts have recently weighed in on the company. Wells Fargo & Company increased their price target on Clorox from $157.00 to $161.00 and gave the stock an "equal weight" rating in a report on Tuesday, February 4th. Barclays increased their price objective on Clorox from $130.00 to $140.00 and gave the stock an "underweight" rating in a research note on Wednesday, February 5th. Royal Bank of Canada reaffirmed a "sector perform" rating and set a $150.00 target price on shares of Clorox in a research report on Thursday, January 30th. StockNews.com lowered Clorox from a "buy" rating to a "hold" rating in a report on Sunday, January 5th. Finally, DA Davidson decreased their price objective on Clorox from $171.00 to $169.00 and set a "neutral" rating for the company in a report on Wednesday, February 5th. Four investment analysts have rated the stock with a sell rating, eleven have given a hold rating and one has given a buy rating to the company's stock. According to MarketBeat.com, the company presently has an average rating of "Hold" and an average target price of $158.21.

Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.